Despite this, the process should be still deeply investigated; however, basing on our results, a synergic interaction between histamine H4 receptors and GCs could be hypothesized in order to validate new therapeutic targets for pulmonary fibrosis. The gene discussed is HRH4; the disease is pulmonary fibrosis.